U.S. Markets closed

Johnson & Johnson beat earnings despite opioid, talc legal challenges

Johnson & Johnson beat earnings expectations for the 3rd quarter, boosted by higher drug sales. This comes despite multimillion dollar legal problems for the company. Yahoo Finance's Ines Ferre joins Alexis Christoforous to discuss.